Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong ...

What if I told you that psoriasis relief starts in the kitchen? Would you agree with me, or would you need a little more convincing? While many believe that managing psoriasis is all about medications ...

The ustekinumab (Stelara; Janssen Biotech) biosimilar DMB-3115 (Imuldosa; Accord BioPharma) demonstrated clinical efficacy and safety comparable to the reference product through 52 weeks in a recent ...

Affecting two to three percent of the global population, psoriasis should be viewed for what it is: a serious systemic ...

A potential for cumulative life course impairment is not completely considered in clinical practice, driving the ...

“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

A German multicentre study reveals strong patient demand for systemic therapy in atopic dermatitis and psoriasis. Learn more about treatment preferences and drivers.

Learn how to pick the best cleansers when you have psoriasis, with expert advice and details on what ingredients to seek out — and which to avoid.

In a combined network meta-analysis, infliximab and adalimumab had the greatest risk for serious infection in patients with plaque psoriasis.

Psoriasis is one of those conditions people assume they understand until they actually live with it. It’s chronic, it’s ...

Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J., Dec. 17, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...